Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

Autor: Helen M. Colhoun, Scott S. Emerson, Steve Marso, G. Kees Hovingh, Kirstine Brown-Frandsen, Steven E. Kahn, John E. Deanfield, Robert F. Kushner, A. Michael Lincoff, Henrik Ravn, Jorge Plutzky, Ildiko Lingvay, Donna H. Ryan, Anders G. Holst, Marianne O. L. Gronning

Publikováno v: American heart journal, 229, 61-69. Mosby Inc.
Ryan, D H, Lingvay, I, Colhoun, H M, Deanfield, J, Emerson, S S, Kahn, S E, Kushner, R F, Marso, S, Plutzky, J, Brown-Frandsen, K, Gronning, M O L, Hovingh, G K, Holst, A G, Ravn, H & Lincoff, A M 2020, ' Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design ', American Heart Journal, vol. 229, pp. 61-69 . https://doi.org/10.1016/j.ahj.2020.07.008

Cardiovascular disease (CVD) is a major cause of morbidity and mortality. Although it has been widely appreciated that obesity is a major risk factor for CVD, treatments that produce effective, durable weight loss and the impact of weight reduction i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ddfd743696aa295b876c97fc2357306
https://doi.org/10.1016/j.ahj.2020.07.008

Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock

Autor: Brian Kolski, Alexander G. Truesdell, David Lasorda, Kirit Patel, Craig Smith, Angela M. Taylor, William W. O'Neill, Aditya Bharadwaj, Joseph Gelormini, Alejandro Lemor, Robert Federici, Steve Marso, Behnam Tehrani, Robert Riley, Mir B Basir, Navin K. Kapur, Josh Todd, Sarah Gorgis

Publikováno v: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 99(3)

Background Increasing vasopressor dose is associated with increasing mortality in patients presenting with acute myocardial infarction and cardiogenic shock (AMICS). It is unknown whether the use of vasopressors is independently harmful or if their u

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ef54c0a7c9067d7ae9c22855413963f
https://pubmed.ncbi.nlm.nih.gov/34343409

Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock

Autor: Alejandro Lemor, Mir B. Basir, Kirit Patel, Brian Kolski, Amir Kaki, Navin K. Kapur, Robert Riley, John Finley, Andrew Goldsweig, Herbert D. Aronow, P. Matthew Belford, Behnam Tehrani, Alexander G. Truesdell, David Lasorda, Aditya Bharadwaj, Ivan Hanson, Thomas LaLonde, Sarah Gorgis, William O'Neill, William W. O'Neill, Theodore Schreiber, Steve Almany, Steven Timmis, Simon Dixon, Thomas Lalonde, Antonious Attallah, Josh Todd, Steve Marso, Charles Wilkins, Nainesh Patel, Shaun Senter, Thomas McRae, Ayaz Rahman, Joseph Gelormini, Navin Kapur, Inder M. Singh, Brian O'Neill, Tijuan Overly, Rahul Sharma, Allison Dupont, Michael Green, Michael Lim, Matheen Khuddus, Christopher Caputo, Timothy Larkin, Raza Askari, Ali Nsair, Yasir Akhtar, Lang Lin, David McAllister, James Park, Simon Gorwara, Raja Nazir, Scott Martin, Malcolm Foster, Craig Smith, Chandhiran Rangaswamy, Omer Zuberi, Robert Federici, John Baker, Ian Cawich, Denes Korpas, Nalin Srivastava, Michael Schaeffer, David Wohns, Aditya Mehra, Nimrod Blank, M. Chadi Alraies, Michael Ashbrook, Osama Abdel-Hafez, Akshay Khandelwal, Khaldoon Alaswad, Tyrell Johnson, Michael Hacala

Publikováno v: JACC. Cardiovascular interventions. 13(10)

Objectives This study sought to compare outcomes of patients enrolled in the NCSI (National Cardiogenic Shock Initiative) trial who were treated using a revascularization strategy of percutaneous coronary intervention (PCI) of multivessel PCI (MV-PCI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0253bdfd0e473353d2c921cd52a01bb0
https://pubmed.ncbi.nlm.nih.gov/32763081